Skip to content

Diagnosis and Response to Treatment Using a Reliable Gastroesophageal Reflux Disease (GERD) Questionnaire: An In Clinical Practice Study

Diagnosis and Response to Treatment Using a Reliable Gerd Questionnaire-an In Clinical Practise Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00963144
Acronym
GQS
Enrollment
250
Registered
2009-08-21
Start date
2009-07-31
Completion date
2009-11-30
Last updated
2010-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux Disease

Keywords

Gerd Questionnaire

Brief summary

The purpose of the study is to determine the applicability and utility of Gerd Q in the diagnosis of GERD and in the assessment of treatment response.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* Patients of either gender aged between 18-79 years of age * Patients must be having symptoms of gastroesophageal reflux disease

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
To determine the applicability and utility of Gerd Q in the diagnosis of GERD and assessment of treatment responseThe applicability and utility of the Gerd Questionnaire will be done on 2 vists- Day 1 and Day 30

Secondary

MeasureTime frame
To assess and monitor the treatment response of patients diagnosed with GERDThe monitoring and assessment of treatment response using the Gerd Questionnaire will be done on 2 vists-Day 1 and Day 30

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026